Delivery Order SPE2DB20D1109-SPE2DB25FP41B
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of 15 milligram dextroamphetamine-amphetamine, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $2,251.46 and a completion date of May 22, 2025. This award is not a set-aside and is part of...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 20 mg dextroamphetamine-amphetamine capsules, a medication used to treat conditions such as ADHD. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,339.35 and a period of performance through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $4,931.94 firm fixed-price contract is for the delivery of 15mg dextroamphetamine sustained-release capsules, a medication commonly used to treat ADHD. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a $1,219.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine ER 20 mg capsules, a medication used to treat ADHD. The contract has an ultimate completion date of June 16, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial...
- This is a $3,252.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for Dextroamphetamine-Amphetamine ER 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The order has a completion date of May 13, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,183.80 firm fixed-price delivery order is for 20 mg dextroamphetamine-amphetamine capsules, without any set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This...
- This federal contract award, valued at $1,300.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,142,281 capsules of dextroamphetamine-amphetamine 20 mg, a medication used to treat conditions such as ADHD. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, valued at $999,999,999.00....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 10 mg tablets of the prescription medication dextroamphetamine-amphetamine, a controlled substance used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm-fixed price of $2,714.03 and a completion date of July 2, 2025. It is not designated as a set-aside contract, indicating...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,873,962 milliliters of dextroamphetamine 5 milligrams per 5 milliliters, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price, non-set-aside delivery order with a ceiling value of $3,379.93 and a performance period...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 mg capsules of the prescription medication dextroamphetamine-amphetamine, which is used to treat conditions such as ADHD. The fixed-price contract has a ceiling value of $4,546.92 and a period of performance through May 6, 2025. This contract is not designated as a set-aside and...